Sandimmune Injection
Product Images NDC 0078-0109

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sandimmune (NDC 0078-0109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Package Label – 50 mg Injection (Sandimmune 01)

This is a description of an injection medication called "Sandimmune" manufactured by Novartis. The medication contains 250mg of cyclosporine and is used for various medical conditions. The instructions and details of usage are not available due to poor scanning quality.*

FDA Label Image

Chemical Structure Of Cyclosporine (Sandimmune 02)

FDA Label Image

Sandoz Logo (Sandimmune 03)

FDA Label Image

Principal Display Panel 25 mg Soft Gelatin Capsules (Sandimmune 04)

SANDIMMUNE is a brand name of cyclosporine capsules which can be identified by the NDC code 0075024015. The capsules are in soft gelatin form and the dosage strength is 25 mg per capsule. This medication is manufactured by Novartis. The rest of the text includes illegible characters and is not available for description.*

FDA Label Image

Principal Display Panel 100 mg Soft Gelatin Capsules (Sandimmune 05)

SANDIMMUNE Soft Gelatin Capsules are a medication containing cyclosporine, manufactured by Novartis. The given text seems to contain some technical specifications and details about the product, its composition, and its production lot number.*

FDA Label Image

Principal Display Panel – Package Label – 100 mg Oral Solution (Sandimmune 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.